A Phase III Randomized, Multicenter, two arm, open label

Project: Research project

Project Details

Description

A Phase III Randomized, Multicenter, two arm, open label trial to evaluate the eddicacy of T-DM1 compared with treatment of physicians choice in patients with HER2-positive metastatic breast cancer who have
StatusFinished
Effective start/end date7/20/116/30/16

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.